Research and Markets (http://www.researchandmarkets.com/research/83fxtc/global_hepatitis) has announced the addition of the "Global Hepatitis B Epidemiology and Patient Flow Analysis - 2015" report to their offering.
This report provides insights into Hepatitis B epidemiology, Hepatitis B diagnosed patients, and Hepatitis B treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Hepatitis B derived from epidemiological analysis, percentage of patients diagnosed with Hepatitis B, and percentage of patients treated with Hepatitis B therapy.
The study helps executives estimate Hepatitis B market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
The report provides estimates and forecasts of Hepatitis B prevalence, Hepatitis B diagnosis rate, and Hepatitis B treatment rate for the period 2014 - 2020. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on collection and interpretation of data from registries, scientific journals and literatures, government databases and other secondary sources.
Key Topics Covered:
1. Hepatitis B: Disease Definition
2. Global Hepatitis B Patient Flow
3. Hepatitis B Patient Flow in the US
4. Hepatitis B Patient Flow in Europe
5. Hepatitis B Patient Flow in Germany
6. Hepatitis B Patient Flow in France
7. Hepatitis B Patient Flow in Spain
8. Hepatitis B Patient Flow in Italy
9. Hepatitis B Patient Flow in UK
10. Hepatitis B Patient Flow in Japan
11. Appendix
For more information visit http://www.researchandmarkets.com/research/83fxtc/global_hepatitis
